The Board of Directors has approved the introduction of the Galaxy Surfactants Limited - Performance Stock Option Plan - 2025 (PSOP-2025), pending shareholder approval.

This plan includes options covering 3,50,000 shares with an exercise price to be determined by the Board, ensuring it is not less than the equity shares' face value on the grant date.

Additionally, the Board has sanctioned the formation of a new wholly-owned subsidiary in Europe, which will have an authorized capital of up to EUR 1,000,000. This strategic move is anticipated to enhance the company's international presence and operational capacity, presenting a positive outlook for Galaxy Surfactants with potential growth and expansion opportunities.